You have to add to cart at least 5 bottles or any program to make checkout.
Published: February 9th, 2016
Categories: Medical Cannabis • News
The CBD Crew, a joint venture between Mr. Nice Seeds and Resin Seeds, achieved a revolutionary THC:CBD ratio of 1:20 with their just released new medical strain 'CBD Therapy'.
Mr. Nice Seeds, a traditional seed company that is responsible for breeding numerous award-winning strains, teamed up with the Spanish breeders of Resin Seeds, to establish the joint venture CBD Crew. These breeders are working hard to develop strains that are suitable to patients and cannabis users who are seeking the therapeutic values of cannabis, so mainly CBD.
The release of CBD Therapy is a revolution for growers that are interested in producing medical cannabis with a very low THC level of 0.5%, and high CBD levels of 8-10%. Most Medical strains reach THC to CBD ratios of 1:1 or 1:2, but CBD Therapy is different. The analysis by two independent laboratories, one in the US (The WercShop), the other one in Europe (Fundación CANNA), is groundbreaking: The continuously tested THC:CBD ratio is 1:20+.
CBD Therapy is a balanced hybrid that consists of 50% sativa, and 50% indica genetics. It has a flowering period of 8-9 weeks and yields up to 500g/m², under a 600-watt light. Flavours of truffle earthiness and sweet fruits are pleasant side effects.
CBD Therapy is available in packs of 5 feminized seeds.
Read more about CBD Therapy by CBD Crew.